Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Eylea 114.3mg/ml


Contraindicated
Embryotoxic and foetotoxic in animals

Contraindicated
Eylea 114.3mg/ml :
Type Medicine Authorised
Originator Biotech (Eylea 114.3mg/ml)
Agent Droguerie R. Pharaon et Fils
Distributor Droguerie R. Pharaon et Fils
Laboratory Bayer
Responsible Party Bayer AG
Manufacturer Bayer AG
Origin Germany
ATC S01LA05

Your comment will appear shortly after approval

Eylea 114.3mg/ml :

Revision Date : 24/02/2015


Effect Frequency
Abnormal sensation in eye Uncommon
Anterior chamber flare Uncommon
Blindness Uncommon
Cataract Common
Cataract cortical Common
Cataract nuclear Common
Cataract subcapsular Common
Cataract traumatic Rare
Cerebrovascular accident Not known
Conjunctival haemorrhage Very Common
Conjunctival hyperaemia (Conjunctival redness) (Conjunctival injection) Common
Corneal abrasion Common
Corneal epithelium defect Uncommon
Corneal erosion Common
Corneal oedema Common
Death Not known
Detachment of retinal pigment epithelium Common
Embolism arterial Not known
Endophthalmitis Uncommon
Eye pain Common
Eyelid irritation Uncommon
Eyelid oedema Common
Foreign body sensation in eyes Common
Hypersensitivity Uncommon
Hypopyon Rare
Injection site haemorrhage Common
Injection site irritation Uncommon
Injection site pain Common
Intraocular pressure increased Common
Iridocyclitis Uncommon
Iritis Uncommon
Lacrimation increased (Epiphora) Common
Lenticular opacities Uncommon
Myocardial infarction Not known
Ocular hyperaemia Common
Punctate keratitis Common
Retinal degeneration Common
Retinal detachment Uncommon
Retinal pigment epithelial tear Common
Retinal vascular thrombosis Uncommon
Uveitis Uncommon
Vision blurred Common
Visual acuity reduced Very Common
Vitreous detachment Common
Vitreous floaters Common
Vitreous haemorrhage Common
Vitritis Rare

Different Units By MoH Code

Eylea 114.3mg/ml  MoH 12162 :
Form Solution for injection
Packaging Bottle (Glass)
Package Size 1x0.07ml
Strength 114.3mg/ml
Storage Condition 2-8°C Protect from light. Do not freeze
Public Price 78332038,03 L.L.
Stratum E1
NSSF ✔
Quarantine ✘
Reg. Number 1325/1
Submission date 2025
Registration Year 03/07/2025


Price Comparison

● Country: Lebanon
● Form: Solution for injection
● Package Size: 1x0.07ml
● Public Price: 78332038.03 LBP ( 78,332,038.03 LBP )
● Pack size unit used: 1
● Cost/Unit: 78332038,03 LBP ( 78,332,038.00 LBP )
● Pricing Date: 10/11/2025

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries

Note

Diabetic macular oedema :
● Cost/Unit: 78332038,03 LBP ( 78,332,038.00 LBP )
● Cost/Day: 78332038,03 LBP ( 78,332,038.00 LBP )
● Cost/Month: 78332038,03 LBP ( 78,332,038.00 LBP )
Macular oedema secondary to RVO :
● Cost/Unit: 78332038,03 LBP ( 78,332,038.00 LBP )
● Cost/Day: 78332038,03 LBP ( 78,332,038.00 LBP )
● Cost/Month: 78332038,03 LBP ( 78,332,038.00 LBP )
Myopic choroidal neovascularisation :
● Cost/Unit: 78332038,03 LBP ( 78,332,038.00 LBP )
● Cost/Day: 78332038,03 LBP ( 78,332,038.00 LBP )
● Cost/Month: 78332038,03 LBP ( 78,332,038.00 LBP )
Neovascular (wet) Age-related macular degeneration (AMD) : (Elderly)
● Cost/Unit: 78332038,03 LBP ( 78,332,038.00 LBP )
● Cost/Day: 78332038,03 LBP ( 78,332,038.00 LBP )
● Cost/Month: 78332038,03 LBP ( 78,332,038.00 LBP )
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info